Drugs / Plain bupivacaine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT02875288 | Dec 2015 → Jan 2020 | neuropathy, painful | United States Naval Medical Center, San Diego | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04685876 Comparator | Jun 2021 → Feb 2024 | — | Edward Mascha | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | plain bupivacaine | “Plain Bupivacaine 0.25%, volume of 30 mL” NCT02875288 ↗ |
| Route | Other | “50 ml of plain bupivacaine 0.5% will be combined with 30 ml of normal saline making a total of 80 ml. 20 ml will be injected at each location of the 4-quadrant TAP block.” NCT04685876 ↗ |